Health Care | Health Care Equipment & Services | Health Care Equipment & Supplies | Health Care Equipment
NASDAQ | Common Stock
IsoPlexis Corporation, a life sciences company, provides solutions for the development of curative medicines and personalized therapeutics in the United States, Canada, the United Kingdom, Belgium, France, the Czech Republic, Spain, Germany, Sweden, Italy, Israel, Switzerland, China and Taiwan, Singapore, Japan, Australia, and Korea.
The company offers single cell proteomics platform, including instruments, chip consumables, and software that provides an end-to-end solution to view of protein function at an individual cellular level.
It provides IsoLight and IsoSpark instruments; IsoCode chips that offer multiplexed chip solutions for single cell functional proteomics; CodePlex chips that provide multiplexed solutions for ultra-low volume bulk samples; and IsoSpeak software that offers dimensional data and automates analysis with an intuitive push button user interface to deliver same day single cell and bulk proteome visualizations, as well as research support and services, and post-warranty services.
The company was incorporated in 2013 and is based in Branford, Connecticut.
As of March 21, 2023, IsoPlexis Corporation operates as a subsidiary of Berkeley Lights, Inc.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 10, 23 | 0.00 Increased by +100.00% | -0.37 Increased by +100.00% |
| Mar 2, 23 | -0.84 Decreased by -29.23% | -0.39 Decreased by -115.38% |
| Nov 10, 22 | -0.47 Increased by +95.59% | -0.43 Decreased by -9.30% |
| Aug 10, 22 | -0.65 Decreased by -35.42% | -0.54 Decreased by -20.37% |
| May 11, 22 | -0.74 Increased by +99.17% | -0.59 Decreased by -25.42% |
| Mar 2, 22 | -0.65 Increased by +99.08% | -0.68 Increased by +4.41% |
| Oct 12, 21 | -10.66 Increased by +52.39% | -0.79 Decreased by -1.25 K% |
| Jul 20, 21 | -0.48 Increased by +98.29% | - |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 22 | 3.36 M Decreased by -65.66% | -34.72 M Increased by +47.16% | Decreased by -1.03 K% Decreased by -53.84% |
| Sep 30, 22 | 4.48 M Increased by +6.94% | -19.94 M Increased by +1.28% | Decreased by -444.69% Increased by +7.69% |
| Jun 30, 22 | 4.00 M Decreased by -6.62% | -26.84 M Decreased by -30.58% | Decreased by -670.16% Decreased by -39.84% |
| Mar 31, 22 | 4.91 M Increased by +51.86% | -29.71 M Decreased by -90.95% | Decreased by -604.97% Decreased by -25.75% |
| Dec 31, 21 | 9.79 M Increased by +187.49% | -65.71 M Decreased by -716.28% | Decreased by -671.47% Decreased by -183.94% |
| Sep 30, 21 | 4.19 M Increased by +27.87% | -20.20 M Decreased by -300.38% | Decreased by -481.73% Decreased by -213.10% |
| Jun 30, 21 | 4.29 M Increased by +105.22% | -20.55 M Decreased by -376.23% | Decreased by -479.23% Decreased by -132.06% |
| Mar 31, 21 | 3.23 M Increased by +100.37% | -15.56 M Decreased by -165.78% | Decreased by -481.11% Decreased by -32.65% |